Xilio Therapeutics, Inc. , a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients.
Xilio Therapeutics stock last closed at $0.90, up 2.05% from the previous day, and has decreased 28.16% in one year. It has overperformed other stocks in the Biotechnology industry by 0.51 percentage points. Xilio Therapeutics stock is currently +44.84% from its 52-week low of $0.62, and -47.18% from its 52-week high of $1.70.
At the moment, there are 51.78M XLO shares outstanding. The market capitalization of XLO is $46.50M. In the last 24 hours, 378,593 XLO shares were traded.
How to Buy Xilio Therapeutics Stock
Not sure how to invest in Xilio Therapeutics stock? Here's how.
Decide where to buy Xilio Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Xilio Therapeutics stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Put funds into your investment account: Select your method of payment and add your information.
Research Xilio Therapeutics stock: The Xilio Therapeutics ticker symbol is XLO. Is Xilio Therapeutics stock a good investment? Should you buy shares of XLO? How do XLO's underlying business fundamentals look? Do top analysts think Xilio Therapeutics is a good buy? Why has XLO's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if XLO is a good stock to buy).
Make your XLO purchase: Decide if you will purchase XLO shares at the current market price or use a limit order to purchase XLO stock at a particular price.
Get updates on your investment in XLO: Create a watchlist to get the latest news on your position in Xilio Therapeutics stock.
Step 1: Decide where to buy Xilio Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy XLO shares.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Technology to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, you need to fill out some personal information so you can invest in XLO today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Xilio Therapeutics stock
Once you have identified the best place to buy Xilio Therapeutics stock, it's important to research their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Xilio Therapeutics Metrics
XLO Price
$0.90
1w %
-21.91%
1y %
-28.16%
5y %
N/A
P/E
-1.1x
P/B
4.35x
P/S
7.24x
PEG
N/A
Revenue
$9.27M
Earnings
-$54.30M
Fore. Rev. Growth
75.45%
Fore. Earn. Growth
N/A
Market Cap
$46.50M
Next Earnings
Jun 13, 2025
Next Dividend
N/A
Xilio Therapeutics Due Diligence Checks
WallStreetZen was created to help average investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on XLO's stock page.
How is XLO stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge XLO's true value.
Using relative valuations metrics:
XLO may be undervalued based on its P/B ratio of 4.35x, relative to Biotechnology industry P/B ratio of 4.37x
No, Xilio Therapeutics doesn't provide an income stream by paying out dividends.
XLO Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your XLO purchase
You have two main order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally fine for most investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and your broker will place your order.
If you require more info about investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Xilio Therapeutics share?
As of May 20, 2025, it costs $0.90 to buy one share of Xilio Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.45, you can buy 0.5 shares of XLO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.